News & Analysis on Clinical Trial Services & Contract Research And Development
One of the hallmarks of cancer is that errors occur when the chromosomes of cells divide and separate during cell division. Researchers have spent many years trying to identify the cellular mechanisms that are involved in keeping this process under...
A new study has provided a 'cautiously optimistic' estimate of spending on drug discovery and other areas of R&D over the next couple of years, which will be music to the ears of technology companies hit by a reluctance to invest in research by the...
In Russia, the Health Ministry suspended the licences of 321 companies manufacturing or trading in counterfeit medicines last year, and a further 200 may also lose their licences following ongoing investigations, according to the RIA Novosti news agency.
Predictions that 2004 could see another wave of consolidation in the pharmaceutical industry were lent further weight yesterday by the announcement that Japanese drug majors Yamanouchi and Fujisawa intend to merge in a $7.7 billion (€6.1bn) deal.